Overview
- 47 inspections across 45 sites are on record.
- 58 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-09-01.
At a glance
Inspections
47
Sites
45
Observations
58
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| B. Braun Medical, Inc. | 1 Sep 2021 | Human Drugs | |
| Geisinger Institutional Review Board | 6 Aug 2021 | Medical Devices & Rad Health | |
| Calvert Laboratories, Inc. | 15 Jul 2021 | Biologics | |
| Aaron N. Hartman, M.D. | 17 Mar 2021 | Biologics | |
| DERMDOX CENTERS FOR DERMATOLOGY | 21 Jan 2021 | Human Drugs | View 483 → |
Sites inspected
B. Braun Medical, Inc.Allentown, United States1 insp.
Geisinger Institutional Review BoardDanville, United States1 insp.
Calvert Laboratories, Inc.Scott Township, United States1 insp.
Aaron N. Hartman, M.D.Midlothian, United States1 insp.
DERMDOX CENTERS FOR DERMATOLOGYSugarloaf, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Margaret E Digennaro6 shared
Brandon J Brookens4 shared
Stephanie C Mangigian3 shared
Cara M Minelli2 shared
Gabrielle J Swain1 shared
Melanie N Daniels1 shared
Nina Yang1 shared
Anastasia I Onuorah1 shared
Anastasia I Offordile1 shared
Mark J Seaton1 shared
Full investigator report
Get the verbatim findings behind Kelly N Kerr's 58 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site